Mechanisms and sites of action of newer angiotensin agonists and antagonists in terms of activity and receptor
- PMID: 194800
Mechanisms and sites of action of newer angiotensin agonists and antagonists in terms of activity and receptor
Abstract
From the myotropic and vasopressor activities of the numerous analogs of angiotensin II, it has been determined that the phenyl group of position 8 possesses the information for biologic response while the aromatic side groups in positions 4 and 6, the guanido group in position 2 and the C-terminal carboxyl are involved in binding to the receptor site. Removal of a side group of the C-terminal phenyalanine yields peptides that bind to the receptor. While many of these have low agonist properties, all have antagonist properties. Modifications in the aromatic side groups affect conformation of the octapeptide. This change may relate to receptor binding but sufficient data are not yet available to determine a correlation pattern. A proposed conformation for angiotensin is given as well as an artist's concept of angiotensin II binding to its membrane receptor utilizing the groups known to be involved in binding. Both angiotensin II and III [des-Asp] angiotensin II stimulate the biosynthesis and release of aldosterone from adrenal glomerulosa cells. Sufficient data are not yet available to determine whether the conversion of angiotensin II to angiotensin III is neccessary for the steroidogenesis activity.
Similar articles
-
Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.Mol Pharmacol. 1984 Nov;26(3):498-508. Mol Pharmacol. 1984. PMID: 6092899
-
[Des-Asp1] angiotensin II: mediator of the renin-angiotensin system?Fed Proc. 1977 Apr;36(5):1766-70. Fed Proc. 1977. PMID: 321257 Review.
-
Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.J Clin Invest. 1978 Jan;61(1):20-31. doi: 10.1172/JCI108919. J Clin Invest. 1978. PMID: 338631 Free PMC article. Clinical Trial.
-
Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.Mol Pharmacol. 1990 Mar;37(3):347-51. Mol Pharmacol. 1990. PMID: 2314387
-
[Angiotensin II receptors in the adrenals].Probl Endokrinol (Mosk). 1980;26(6):74-83. Probl Endokrinol (Mosk). 1980. PMID: 6256730 Review. Russian. No abstract available.
Cited by
-
Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).Adv Pharmacol. 2010;59:197-233. doi: 10.1016/S1054-3589(10)59007-0. Adv Pharmacol. 2010. PMID: 20933203 Free PMC article.
-
An evolving story of angiotensin-II-forming pathways in rodents and humans.Clin Sci (Lond). 2014 Apr;126(7):461-9. doi: 10.1042/CS20130400. Clin Sci (Lond). 2014. PMID: 24329563 Free PMC article. Review.
-
[Leu]enkephalin stimulates carbohydrate metabolism in isolated hepatocytes and kidney tubule fragments by interaction with angiotensin II receptors.Biochem J. 1989 Feb 1;257(3):705-10. doi: 10.1042/bj2570705. Biochem J. 1989. PMID: 2930480 Free PMC article.
-
The effect of analogues of angiotensin II on drinking and cardiovascular responses to central angiotensin II in the rat.J Physiol. 1991 Nov;443:513-8. doi: 10.1113/jphysiol.1991.sp018848. J Physiol. 1991. PMID: 1822536 Free PMC article.
-
Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide.Proc Natl Acad Sci U S A. 1988 Jun;85(11):4095-8. doi: 10.1073/pnas.85.11.4095. Proc Natl Acad Sci U S A. 1988. PMID: 3375255 Free PMC article.